ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,018.39
-0.34%
Dow Jones
37,903.29
0.23%
US Dollar vs MXN
16.93507
-0.05%
Brent Oil
84.03
0.59%
Bitcoin
57,623.79
-1.05%
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. BioCryst Pharmaceuticals Inc (BCRX)

  7. BioCryst Pharmaceuticals Inc (BCRX) Noticias

BCRX BioCryst Pharmaceuticals Inc

4.57
0.00 (0.00%)
01 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
BioCryst Pharmaceuticals Inc BCRX NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
0.00 0.00% 4.57 19:00:00
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
4.57
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
22/4/202406:00GLOBEBioCryst to Report First Quarter 2024 Financial Results on..
17/4/202403:30GLOBEBioCryst Announces Approval of ORLADEYO® (berotralstat) by..
03/4/202406:00GLOBEBioCryst Reports Inducement Grants Under Nasdaq Listing Rule..
25/3/202415:01GLOBEBioCryst to Present at Upcoming Investor Conferences
05/3/202406:01GLOBEBioCryst Reports Inducement Grants Under Nasdaq Listing Rule..
04/3/202416:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/3/202415:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202416:05EDGAR2Form S-3ASR - Automatic shelf registration statement of..
26/2/202406:05EDGAR2Form 8-K - Current report
26/2/202406:00GLOBEBioCryst Reports Fourth Quarter and Full Year 2023 Financial..
26/2/202404:57IHMARKETNEWSU.S. Index Futures Dip Amid Inflation Data Anticipation, Oil..
23/2/202406:00GLOBEBioCryst Presents New Real-world Data Showing Rapid,..
21/2/202415:01GLOBEBioCryst to Present at Upcoming Investor Conferences
19/2/202406:54GLOBEBioCryst Launches ORLADEYO® (berotralstat) in Italy
14/2/202415:21EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202408:02EDGAR2Form SC 13G - Statement of acquisition of beneficial..
12/2/202406:00GLOBEBioCryst to Report Fourth Quarter 2023 Financial Results on..
05/2/202406:00GLOBEBioCryst to Present New ORLADEYO® (berotralstat) Real-world..
02/2/202406:00GLOBEBioCryst Reports Inducement Grants Under Nasdaq Listing Rule..
24/1/202416:23EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
18/1/202416:21EDGAR2Form 8-K - Current report
08/1/202406:02EDGAR2Form 8-K - Current report
05/1/202415:01GLOBEBioCryst Announces Preliminary Full Year 2023 ORLADEYO®..
04/1/202415:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202415:01GLOBEBioCryst Reports Inducement Grants Under Nasdaq Listing Rule..
03/1/202406:00GLOBEBioCryst to Present at 42nd Annual J.P. Morgan Healthcare..
20/12/202315:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/12/202315:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/12/202315:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/12/202315:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/12/202315:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/12/202306:00GLOBEBioCryst Announces Publication of Data from Open-label..
18/12/202315:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/12/202315:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/12/202315:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/12/202315:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/12/202315:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/12/202315:01GLOBEBioCryst Reports Inducement Grants Under Nasdaq Listing Rule..
01/12/202315:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/12/202315:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/12/202306:37EDGAR2Form 8-K - Current report
30/11/202308:04EDGAR2Form 8-K - Current report
29/11/202306:00GLOBEBioCryst Announces Approval of ORLADEYO® (berotralstat) by..
21/11/202315:01GLOBEBioCryst to Present at Upcoming Investor Conferences
21/11/202306:00GLOBEBioCryst Launches ORLADEYO® (berotralstat) in Spain
10/11/202306:00GLOBEBioCryst Presents New Real-world Data Showing Reduced Attack..
08/11/202315:29EDGAR2Form S-8 - Securities to be offered to employees in employee..
08/11/202315:12EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06/11/202315:01GLOBEBioCryst Reports Inducement Grants Under Nasdaq Listing Rule..
03/11/202311:16EDGAR2Form 8-K - Current report

Su Consulta Reciente

NASDAQ
BCRX
BioCryst Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados